SHJ002 Ophthalmic Solution

· Sunhawk Vision Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHJ002 Ophthalmic Solution, covering 2025-08-22 to 2025-08-22. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SHJ002 Ophthalmic Solution in the Treatment of Corneal Erosion in Sjogren's Patients [Phase 2]

See pricing